Neuroscience

Researchers introduce a biomarker to indicate whether someone is struggling with the inflexible thinking associated with the disorder.

A small molecule inhibitor is key to potentially reversing CTNNB1 syndrome, according to a new study from a School of Medicine professor and colleagues.

Neuroscientist Phil Haydon hopes his recent win in the Newport Bermuda sailing race will help inspire others with epilepsy to live fuller lives

Najah Walton reflects on the impact of Tufts pathway programs in her academic journey.

A researcher at Tufts School of Medicine explains how brain development — as well as current events — can influence decision-making in adolescence

Tufts University School of Medicine researchers develop imaging technology that records neuronal activity throughout the brain during the first weeks of recovery.

Researchers across the university are attacking the disease from all angles and will use the funding to identify better ways to prevent, track, and treat Lyme and its long-term consequences

Tufts was awarded 28 utility patents this year, demonstrating success from research across the university

A new study by Tufts researchers found a molecule that could be a target for treatment in patients who have become resistant to traditional anti-seizure drugs